Narrative Update • Aug 07
Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedAug 09, 2026
DataAggregated Company Financials
Companies9
- 7D-0.2%
- 3M12.1%
- 1Y22.9%
- YTD10.6%
The Biotech industry has been flat over the last week, but CCME Global has lost 23%. As for the the longer term, the industry is up 23% over the past 12 months. Looking forward, earnings are forecast to grow by 47% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 10 Aug 2026 | ₹744.2b | ₹185.0b | ₹6.4b | 15.1x | 116.5x | 4x |
| Wed, 08 Jul 2026 | ₹719.9b | ₹181.4b | ₹4.5b | 33.8x | 160x | 4x |
| Fri, 05 Jun 2026 | ₹730.7b | ₹181.5b | ₹4.5b | 29.4x | 162.4x | 4x |
| Sun, 03 May 2026 | ₹627.3b | ₹180.7b | ₹6.6b | 48.4x | 94.7x | 3.5x |
| Tue, 31 Mar 2026 | ₹620.7b | ₹180.6b | ₹6.7b | 53.9x | 93x | 3.4x |
| Thu, 26 Feb 2026 | ₹679.5b | ₹180.6b | ₹6.7b | 57.5x | 101.9x | 3.8x |
| Sat, 24 Jan 2026 | ₹631.9b | ₹177.0b | ₹5.5b | 90.7x | 114.5x | 3.6x |
| Mon, 22 Dec 2025 | ₹572.6b | ₹177.0b | ₹5.5b | 86.3x | 103.8x | 3.2x |
| Wed, 19 Nov 2025 | ₹606.7b | ₹176.7b | ₹5.5b | 96.9x | 110.2x | 3.4x |
| Fri, 17 Oct 2025 | ₹527.4b | ₹169.8b | ₹4.7b | 57.9x | 113x | 3.1x |
| Sun, 14 Sep 2025 | ₹537.4b | ₹169.4b | ₹4.6b | 63.9x | 116x | 3.2x |
| Tue, 12 Aug 2025 | ₹503.1b | ₹168.8b | ₹4.4b | 54.9x | 113.5x | 3x |
| Thu, 10 Jul 2025 | ₹546.2b | ₹163.8b | ₹10.6b | 52.7x | 51.4x | 3.3x |
| Sat, 07 Jun 2025 | ₹445.1b | ₹163.8b | ₹10.6b | 48.1x | 41.9x | 2.7x |
| Mon, 05 May 2025 | ₹436.5b | ₹158.8b | ₹8.5b | 47.9x | 51.1x | 2.7x |
| Wed, 02 Apr 2025 | ₹452.2b | ₹158.8b | ₹8.5b | 49.3x | 53x | 2.8x |
| Fri, 28 Feb 2025 | ₹411.6b | ₹158.9b | ₹8.4b | 46.4x | 49.3x | 2.6x |
| Sun, 26 Jan 2025 | ₹709.0b | ₹162.0b | ₹11.3b | 57.2x | 62.6x | 4.4x |
| Tue, 24 Dec 2024 | ₹449.6b | ₹159.6b | ₹14.5b | 42.1x | 30.9x | 2.8x |
| Thu, 21 Nov 2024 | ₹445.3b | ₹159.6b | ₹14.5b | 41.2x | 30.6x | 2.8x |
| Sat, 19 Oct 2024 | ₹458.0b | ₹157.7b | ₹15.7b | 45.6x | 29.1x | 2.9x |
| Mon, 16 Sep 2024 | ₹504.3b | ₹157.7b | ₹15.7b | 36.8x | 32.1x | 3.2x |
| Wed, 14 Aug 2024 | ₹444.0b | ₹157.4b | ₹15.9b | 29.3x | 27.8x | 2.8x |
| Fri, 12 Jul 2024 | ₹462.9b | ₹157.4b | ₹10.4b | 47x | 44.7x | 2.9x |
| Sun, 09 Jun 2024 | ₹431.9b | ₹157.7b | ₹10.4b | 45.2x | 41.7x | 2.7x |
| Tue, 07 May 2024 | ₹389.1b | ₹155.4b | ₹12.0b | 48.1x | 32.5x | 2.5x |
| Thu, 04 Apr 2024 | ₹355.3b | ₹155.4b | ₹12.0b | 36.3x | 29.6x | 2.3x |
| Sat, 02 Mar 2024 | ₹356.6b | ₹155.4b | ₹12.0b | 37.8x | 29.7x | 2.3x |
| Mon, 29 Jan 2024 | ₹340.4b | ₹145.0b | ₹5.3b | 55.9x | 64.8x | 2.3x |
| Wed, 27 Dec 2023 | ₹330.5b | ₹145.0b | ₹5.3b | 54.1x | 62.9x | 2.3x |
| Fri, 24 Nov 2023 | ₹310.2b | ₹145.0b | ₹5.3b | 53.6x | 59x | 2.1x |
| Sun, 22 Oct 2023 | ₹307.2b | ₹133.7b | ₹4.8b | 36.5x | 64.6x | 2.3x |
| Tue, 19 Sep 2023 | ₹356.9b | ₹133.8b | ₹4.8b | 30.3x | 74.6x | 2.7x |
| Thu, 17 Aug 2023 | ₹335.2b | ₹133.8b | ₹4.8b | 28.2x | 70.1x | 2.5x |
Price to Earnings Ratio
70.1x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 117x which is higher than its 3-year average PE of 70.9x.
- The 3-year average PS ratio of 3.0x is lower than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 10% per year over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 1.27% | |
| Healthcare | 0.61% | |
| Biotech | -0.15% | |
| Biotech | -0.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹426.35 | 0.2% +₹1.1b | 24.2% | PE139.4x | |
| 524663 Bharat Immunologicals & Biologicals | ₹16.07 | 4.4% +₹28.9m | -24.9% | n/a | |
| 532039 Zenotech Laboratories | ₹44.89 | 0.8% +₹21.4m | -23.7% | PS6.8x |